Reports Q4 revenue $5.32B, consensus $5.33B. GE HealthCare (GEHC) President and CEO Peter Arduini said, “We were pleased with the strong momentum in orders, backlog and book-to-bill that we saw in the fourth quarter. We also continued to deliver revenue growth driven by demand in our Advanced Visualization Solutions and Pharmaceutical Diagnostics businesses, with overall strength in the U.S., and robust margin expansion and earnings growth. Customer interest in new, differentiated products contributed to orders growth and recurring revenue in the year. We remain committed to our precision care strategy for growth, supported by innovation, productivity initiatives, and commercial execution.”
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Notable companies reporting before tomorrow’s open
- Notable companies reporting before Monday’s open
- Ge Healthcare Technologies Inc. (GEHC) Q4 Earnings Cheat Sheet
- GE Healthcare Invests $138 million in Irish Factory Expansion to Boost Medical Imaging
- GE HealthCare to invest $138M in manufacturing site in Ireland